Clinical Trial Update: High Dose D-Serine as Adjuvant Treatment for Recent Onset Schizophrenia [Phase 2]

View source ↗

Summary

An update on a Phase 2 trial examining high-dose D-serine as an adjuvant treatment for recent-onset schizophrenia. The current status of the trial is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Schizophrenia

Drugs mentioned

• D-serine (D-serine)

Snippet

Sponsor: Hadassah Medical Organization | Conditions: Schizophrenia | Phase 2 | Status: UNKNOWN